NATCO Pharma Limited (NSE:NATCOPHARM)
India · Delayed Price · Currency is INR 1,027.55
+25.65 (2.56%)
Apr 2, 2026, 3:30 PM IST
NATCO Pharma Market Cap
NATCO Pharma has a market cap or net worth of 184.04 billion as of April 2, 2026. Its market cap has increased by 30.39% in one year.
Market Cap
184.04B
Enterprise Value
154.65B
Revenue
45.63B
Ranking
n/a
PE Ratio
11.82
Stock Price
1,027.55
Market Cap Chart
Since March 31, 1999, NATCO Pharma's market cap has increased from 429.39M to 184.04B, an increase of 42,761.96%. That is a compound annual growth rate of 25.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 184.04B | 13.79% |
| Dec 31, 2025 | 161.75B | -34.91% |
| Dec 31, 2024 | 248.48B | 70.99% |
| Dec 29, 2023 | 145.32B | 41.73% |
| Dec 30, 2022 | 102.53B | -37.85% |
| Dec 31, 2021 | 164.98B | -5.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 382.64B |
| Ajanta Pharma | 350.32B |
| Emcure Pharmaceuticals | 302.49B |
| Gland Pharma | 281.07B |
| Wockhardt | 191.04B |
| Piramal Pharma | 189.23B |
| Eris Lifesciences | 179.72B |
| Alembic Pharmaceuticals | 130.37B |